Predictive and prognostic biomarkers in the era of new targeted therapies for chronic lymphocytic leukemia
Author:
Affiliation:
1. Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;
2. Institute of Oncology Research, Bellinzona, Switzerland
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,Hematology
Link
https://www.tandfonline.com/doi/pdf/10.1080/10428194.2016.1250264
Reference67 articles.
1. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends
2. Biomarker: Predictive or Prognostic?
3. Is It Time to Redefine Prognostic and Predictive in Oncology?
4. Mutations driving CLL and their evolution in progression and relapse
5. Non-coding recurrent mutations in chronic lymphocytic leukaemia
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunities;HemaSphere;2024-07
2. Prognostication in chronic lymphocytic leukemia;Seminars in Hematology;2024-04
3. Biological relevance of ZNF224 expression in chronic lymphocytic leukemia and its implication IN NF-kB pathway regulation;Frontiers in Molecular Biosciences;2022-11-09
4. Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study);Clinical Lymphoma Myeloma and Leukemia;2021-12
5. The Biology of Chronic Lymphocytic Leukemia;The Cancer Journal;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3